Show simple item record

The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

dc.contributor.authorGumusay, O.
dc.contributor.authorBenekli, M.
dc.contributor.authorBerk, V.
dc.contributor.authorDane, F.
dc.contributor.authorOzkan, M.
dc.contributor.authorCetin, B.
dc.contributor.authorTAŞTEKİN, Didem
dc.contributor.authorAktas, B.
dc.contributor.authorGuler, T.
dc.contributor.authorKaplan, M. A.
dc.date.accessioned2022-02-18T10:45:17Z
dc.date.available2022-02-18T10:45:17Z
dc.identifier.citationCetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A. , Berk V., Gumusay O., Dane F., Ozkan M., Benekli M., "The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival", European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49
dc.identifier.othervv_1032021
dc.identifier.otherav_b96c9999-5062-4044-9b55-6853cdb85138
dc.identifier.urihttp://hdl.handle.net/20.500.12627/179854
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.subjectTıp
dc.titleThe effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival
dc.typeBildiri
dc.contributor.departmentGazi Üniversitesi , ,
dc.identifier.volume49
dc.contributor.firstauthorID3381291


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record